Another Viagra melanoma lawsuit has been filed, this time by a California man who claims Pfizer’s drug caused skin cancer to form and spread across his upper body.
Viagra belongs to a group of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which are intended to treat erectile dysfunction in men. Since its approval by the U.S. Food and Drug Administration (FDA) in 1998, Viagra has been prescribed to over ...
continue reading...The Huffington Post reports on a new study that claims Viagra does not lead to increased risk of melanoma, a common form of skin cancer, in men who use it. Instead, the researchers behind the NYU Langone Medical Center study contend that melanoma in Viagra users is the result of lifestyle issues. These findings conflict with those provided by a study in June 2014, ...
A study published in the April 2014 issue of the Journal of the American Medical Association Internal Medicine indicates that there may be a link between the popular erectile dysfunction drug Viagra and skin cancer. Viagra, also known as sildenafil citrate, is a drug used to treat erectile dysfunction, a condition that occurs in men in which they are unable to obtain or maintain an erection. The study indicates that men who had used Viagra had ...
continue reading...
A new cancer vaccine has failed its primary-stage development trials. A story by MedPage Today reports that GlaxoSmithKline PLC (“GSK”) has announced its experimental cancer vaccine MAGE-A3 has failed to meet requirements to slow progressions to advanced stages of Melanoma.
This is a huge setback for the pharmaceutical giant. GSK claims the drug did not meet a primary goal in a late-stage trial in patients with melanoma, which was hoped to significantly extend the disease-free life of ...
continue reading...
The U.S. Food and Drug Administration has proposed requiring tanning beds to include a label warning that the devices increase the risk of skin cancer and shouldn’t be used by people younger than 18.
According to a USA Today story, the FDA currently regulates the sunlamps in tanning beds as class 1 devices, which are considered low risk and don’t require review before going on the market.
The FDA’s proposal would change ...
continue reading...
